Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada
· Delayed Price · Currency is CAD 0.0950
-0.0100 (-9.52%)
Apr 28, 2026, 3:51 PM EST
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 657.14K CAD in the quarter ending November 30, 2025, with 30.98% growth. This brings the company's revenue in the last twelve months to 2.78M, up 72.84% year-over-year. In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M with 104.34% growth.
Revenue (ttm)
2.78M
Revenue Growth
+72.84%
P/S Ratio
4.66
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.96M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Britannia Life Sciences | 157.68K |
| Pharmala Biotech Holdings | 889.57K |
| Innovotech | 4.53M |
| Glow Lifetech | 2.05M |
| COSCIENS Biopharma | 10.28M |
Rapid Dose Therapeutics News
- 22 days ago - Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt - Newsfile Corp
- 5 months ago - Rapid Dose Completes Extension to Promissory Notes - Newsfile Corp
- 5 months ago - Rapid Dose Announces Extension to Promissory Notes - Newsfile Corp
- 3 years ago - Rapid Dose Announces Proposed Private Placement Financing - Business Wire
- 3 years ago - Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order - Business Wire
- 3 years ago - Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program in Partnership with Maryland Tech Council and Canada's Trade Commissioner Service - Business Wire
- 3 years ago - Rapid Dose Therapeutics Enters Supplier and Purchase Agreement with a Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products - Business Wire
- 3 years ago - Rapid Dose Therapeutics Confirms Delay in Filing Annual Financial Statements and Issuance of Failure-to-File Cease Trade Order - Business Wire